"It is with great enthusiasm that we introduce the second edition of Pocket Oncology. The first edition was well received, and given many exciting new developments in the oncology, we are now eager to release an updated second edition. Several new sections have been added to this updated edition, including information on chimeric antigen receptor (CAR) T-cell therapy, immunotherapy toxicity, and novel oral anticoagulants. We have additionally incorporated more information about precision targeted therapeutic strategies. Each disease section has been updated to reflect cancer care in 2017"--Provided by publisher.
Pocket Radiation Oncology is a practical, high-yield reference offering current, evidence-based practices and expert guidance from physicians at the world-renowned MD Anderson Cancer Center.
This crucial material makes the book an ideal companion for the practicing physician during rounds and other clinical settings.
This assemblage of practical clinical information on oncology nursing is presented in a concise, easy-to-use format.
This Fifth Edition is fully updated and includes a sixteen-page color insert with key and classic abnormal images.
This handbook is designed to serve as a compact, up-to-date, and easy-to-use reference on the clinical features and pathology of ocular tumors.
This Manual of Interventional Oncology by Douglas Coldwell is the culmination of more than 30 years of training, hands-on practice, and skills learned from oncology colleagues.
This is a highly practical resource about the specific technical aspects of delivering radiation treatment.
With publication of the MD Anderson Manual of Medical Oncology, the editorial board of this prestigious institution makes available for the first time a resource that meets the needs of clinicians for an authoritative, accessible guide to ...
Pocket Nephrology is a practical, high-yield reference offering current, evidence-based practices and expert guidance from physicians at the world-renowned Columbia University Medical Center.
This handbook incorporates changes such as the understanding of the science of cancer, novel therapies in breast, lung, renal, and melanoma, molecular sub-classification of common solid cancers, personalized therapy approaches, new agents ...